[ U.S. CDMRP – Lung Cancer Research Program Concept Award | Research Funding ]

Thumbnail

Event details

Date 06.04.2021
Category Call for proposal
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Lung Cancer Research Program (LCRP) Awards. The FY21 LCRP Concept Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer.  The Concept Award is not intended to support an incremental progression of an already established research project; instead, this award mechanism allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations by supporting high-risk studies that have the potential to reveal entirely new avenues for investigation.  Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation.  Research completed through a Concept Award may generate sufficient preliminary data to enable the PI to prepare an application for future research. 
Presentation of preliminary data is not consistent with the intent of the Concept Award mechanism.  While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.

In addition, all applications for LCRP funding must specifically address at least one of the Areas of Emphasis as directed by Congress and have direct relevance to military health. The FY21 LCRP Topic Areas are listed at the end of this announcement.

Funding:        max. $100’000

Duration:      1 year

Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible.

How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Note: Application review being a blinded process, it is prohibited to identify the PI or the host organization in the letter of intent.

Pre-Application Deadline: 5:00 p.m. Eastern time (ET), April 6, 2021
Full Application Deadline: 11:59 p.m. ET, April 20, 2021 (invitation not required)

Grants.gov Funding Opportunity Number: W81XWH-21-LCRP-CA

Further information
  • To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-21-LCRP-CA
  • For questions about the eBRAP or Grants.gov platforms, contact the Research Office.

Areas of Emphasis:
  • Identify innovative strategies for prevention of the occurrence of lung cancer
  • Identify innovative strategies for the screening and early detection of lung cancer
  • Understand the molecular mechanisms of initiation and progression to lung cancer
  • Understand contributors to lung cancer development other than tobacco
  • Identify innovative strategies for the treatment of lung cancer
  • Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer
  • Develop or optimize prognostic or predictive markers to assist with therapeutic decision making
  • Understand mechanisms of resistance to treatment (primary and secondary) 
  • Identify innovative strategies for lung cancer care delivery (clinical management/ surveillance/symptom management)
  • Understand factors that contribute to the health disparities in lung cancer, such as biological contributors; environmental, social, and cultural factors; and access to health care

Practical information

  • General public
  • Free

Contact

Tags

research funding

Event broadcasted in

Share